Coverage changes drive sharp decline in Massachusetts GLP-1 use
State House News Service reports benefit design shifts, not patient demand, behind the drop in GLP-1 prescriptions.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 17 12:12 ETSource: State House News Service
The wire
- 01Reported decline in GLP-1 utilization follows insurance coverage changes.
- 02Shows payer policy is now a primary determinant of obesity drug access.
- 03Long-term effects on patient outcomes and spending are unknown.
From the source
Read at news.google.comCoverage changes spark sharp decline in GLP-1 usage